Bausch Health Companies BHC
NYSE BHC
$6.44 -0.37 (-5.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015)

Bausch Health Companies (BHC) posted Current Deferred Tax Assets of $727.2 million for Q3 2015, up 2.22% sequentially from $711.4 million in Q2 2015, and up 129.84% YoY from $316.4 million in Q3 2014.

Bausch Health Companies (BHC) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends

Bausch Health Companies has reported Current Deferred Tax Assets for 6 years, with the latest figure at $727.2 million in Q3 2015.

  • Quarterly Current Deferred Tax Assets rose 129.84% year-over-year to $727.2 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $727.2 million (up 129.84% YoY) and the FY2014 annual result came in at $193.3 million, down 47.32% from the prior year.
  • Current Deferred Tax Assets improved to $727.2 million in Q3 2015 per BHC's latest filing, from $711.4 million in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $727.2 million in Q3 2015 and troughed at $77.5 million in Q3 2011.
  • A 5-year average of $252.5 million and a median of $196.5 million in 2015 frame the typical range for Current Deferred Tax Assets.
  • The sharpest annual moves came in 2011 and 2014: Current Deferred Tax Assets soared 540.48% in 2011, then slumped 47.32% in 2014.
  • Over 5 years, Current Deferred Tax Assets stood at $148.5 million in 2011, then surged by 31.36% to $195.0 million in 2012, then soared by 88.15% to $366.9 million in 2013, then slumped by 47.32% to $193.3 million in 2014, then soared by 276.2% to $727.2 million in 2015.
  • According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $727.2 million, $711.4 million, and $196.5 million for Q3 2015, Q2 2015, and Q1 2015 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Bausch Health Companies 2.42 Bn 586.38 Mn 2.10 Bn

Historic Data

Download Data
DateValue
Sep 30, 2015 727.20 Mn
Sep 30, 2015 727.20 Mn
Jun 30, 2015 711.40 Mn
Jun 30, 2015 711.40 Mn
Dec 31, 2014 193.30 Mn
Dec 31, 2014 193.30 Mn
Sep 30, 2014 316.40 Mn
Sep 30, 2014 316.40 Mn
Jun 30, 2014 309.80 Mn
Jun 30, 2014 309.80 Mn
Mar 31, 2014 315.30 Mn
Mar 31, 2014 315.30 Mn
Dec 31, 2013 366.90 Mn
Dec 31, 2013 366.90 Mn
Sep 30, 2013 221.93 Mn
Sep 30, 2013 221.93 Mn
Jun 30, 2013 198.67 Mn
Jun 30, 2013 198.67 Mn
Mar 31, 2013 198.88 Mn
Mar 31, 2013 198.88 Mn